10.09.2019

Bcs Classification Of Drug

DrugDrugsBcs Classification Of Drug

Bcs Classification Of Drugs Fda

Since 2000, developers of immediate-release oral drugs have been able to request waivers of in vivo bioequivalence studies based on the Food and Drug Administration’s (FDA’s) Biopharmaceutics Classification System (BCS).

Biopharmaceutics classification system (BCS) class IV compounds, exhibits least oral bioavailability, low solubility and intestinal permeability among all pharmaceutical classes of drugs. Thus, these drugs need more compatible and efficient delivery system. Since, their solubility in various medium, remains a limitation so, polymeric nano coacervates based drug loading with modified approach for them may prove to be a solution ahead. Nobody's fool full movie torrent. Therefore, in present study Chitosan is opted for encapsulating the BCS class IV drug (Hydrochlorothiazide) to attain better stability, enhanced permeability and lower toxicity. For this study, Hydrochlorothiazide (HCTZ) was opted for formulating chitosan based nano-coacervate system. Optimized HCTZ nanocoacervates exhibited the average particle size of 91.39 ± 0.75 nm with Poly-dispersity index score of 0.159 ± 0.01, indicating homogeneity of colloidal solution. Zeta potential and encapsulation efficiency of HCTZ nanocoacervates were recorded as -18.9 ± 0.8 mV and 76.69 ± 0.82% respectively.

Further, from TEM and SEM evaluation the average particle size for the same were found in conformity (35-50 nm), with almost spherical morphology. Also, the EDX (Electron Dispersive X-ray) spectrometry and FT - IR analysis of optimized formulation indicated the balanced chemical composition and interaction between the polymeric molecules. The HCTZ nano coacervates showed the linear diffusion profile through the dialysis membrane.

We can conclude from the present study that the optimized HCTZ nano coacervates may prove to be a suitable potential option for effective delivery of BCS class IV drugs. Download full-text PDF Source DOI Listing PMC. What are PubFacts Points? PubFacts points are rewards to PubFacts members, which allow you to better promote your profile and articles throughout PubFacts.com. How do I earn PubFacts Points? Each member is given 50 PubFacts points upon signing up.

You can earn additional points by completing 100% of your profile, creating and participating in discussions, and sharing other members research. What can I do with PubFacts Points? Currently, you can use PubFacts Points to promote and increase readership of your articles.